We only have access to/collect information that you voluntarily give us via email or other direct contact. We are the sole owners of such information and we will not sell or rent this information to anyone.
We will use your information to respond to you, regarding the reason you contacted us. Occasionally Mirabilis hires other companies to provide services for us, which may require that they have access to some of the information collected. Such companies are required to use the information only to perform the services Mirabilis hired them to provide, and to maintain the confidentiality of the information. Mirabilis does not provide, sell, or lease information about you to any third parties for their marketing use. Mirabilis will release information about you if you direct us to do so, if we are required by law, or if necessary to protect and defend the rights or property of Mirabilis.
Please contact by email at firstname.lastname@example.org if you wish to opt out of any future contacts from us or if you wish do the following:
We take precautions to protect your information. We discourage you from submitting sensitive information, such as your medical history or credit card information, via the email link on our website. Mirabilis is committed to protecting the security of your personal information, and we take reasonable physical, electronic, and administrative safeguards to help protect your personal information from unauthorized or inappropriate access. We also restrict access to information about you to individuals at Mirabilis who need to know the information in accordance with their job responsibilities, and such access is only made from secured locations. It is your responsibility to protect the confidentiality of your passwords, account information, and any other access features associated with your use of this Site.
The Mirabilis web site may contain links to other sites. Mirabilis is not responsible for the content or privacy practices of such other sites. Mirabilis encourages individuals to be aware when they leave the Mirabilis site and to read the privacy statements of any other site that collects personally identifiable information. The Mirabilis website does not install cookies on a viewer’s computer or device, nor use other means of tracking users.
It is the policy of Mirabilis Medica, Inc. (Mirabilis) to comply with the EU-US Privacy Shield Framework (Privacy Shield).
In accordance with the provisions of the Privacy Shield, individuals will have access to their own Personal Data that the organization holds and be able to correct, amend, or delete that information where it is inaccurate, or has been processed in violation of the Principles of the Privacy Shield, except where the burden or expense of providing access would be disproportionate to the risks to the individual's privacy in the case in question, or where the rights of persons other than the individual would be violated.
If an individual requests access to their Personal Data the individual may be asked to provide the context and provide other information to verify their identity.
In compliance with the US-EU Privacy Shield Principles, Mirabilis commits to resolve complaints about privacy and our collection or use of Personal Data. EU individuals with questions or concerns about the use of Personal Data should contact the company at: email@example.com.
If a Customer's question or concern cannot be satisfied through this process Mirabilis has further committed to refer unresolved privacy complaints under US-EU Privacy Shield to an independent dispute resolution mechanism operated by the Council of Better Business Bureaus.
If an individual does not receive timely acknowledgement of the complaint, or if the complaint is not satisfactorily addressed by Mirabilis, EU individuals may bring a complaint before the BBB EU Online Privacy Shield. Information about how to file a complaint before the BBB EU Privacy Shield program can be found at: www.bbb.org/EU-privacy-shield/for-eu-consumers/
Caution: The Mirabilis System is limited by federal law to investigatinoal use in the United States.